Therapeutic Segment: Antibiotic

Generic Name: Ciprofloxacin (as HCl)


In adults with:
-Lower respiratory tract infections due to Gram-negative bacteria: exacerbations of chronic obstructive pulmonary disease, broncho-pulmonary infections in cystic fibrosis or in bronchiectasis, pneumonia.
-Chronic suppurative otitis media.
-Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria
-Urinary tract infections
-Genital tract infections: gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae, epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae and pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae.
-Infections of the gastro intestinal tract (e.g. travellers’ diarrhea)
-Intra-abdominal infections
-Infections of the skin and soft tissue caused by Gram-negative bacteria
-Malignant external otitis
-Infections of the bones and joints
-Prophylaxis of invasive infections due to Neisseria meningitidis
-Inhalation anthrax (post-exposure prophylaxis and curative treatment)
-Typhoid fever caused by Salmonella typhi.

Indicated in children and adolescents with:
-Broncho-pulmonary i nfections in cystic fibrosis caused by Pseudomonas aeruginosa
-Complicated urinary tract infections and pyelonephritis
-Inhalation anthrax (post-exposure prophylaxis and curative treatment)

Available as:

  • 250 mg
  • 500 mg


  • 125 mg/5ml
  • 250 mg/5ml